News All PostNewsAxxam: A new generation screening collection (AXXDIV2.0) is now available for drug discovery programs26 September 2013read more >Axxam announces the appointment of Dr. Doris Hafenbradl as Vice-President, Discovery Services18 January 2013read more >Axxam SpA receives funding for the development of compounds for prevention and treatment of disability in Multiple Sclerosis22 May 2012read more >Axxam receives EUR 2.3 million grant from the Italian Ministry of Research to support innovative drug discovery programs3 March 2012read more >Axxam enhances its screening capacity with the acquisition of QPatch 16X2 February 2012read more >Axxam Advances its High-Throughput Screening with Genedata Screener16 December 2011read more >Load MoreEnd of Content.
Axxam: A new generation screening collection (AXXDIV2.0) is now available for drug discovery programs26 September 2013read more >
Axxam announces the appointment of Dr. Doris Hafenbradl as Vice-President, Discovery Services18 January 2013read more >
Axxam SpA receives funding for the development of compounds for prevention and treatment of disability in Multiple Sclerosis22 May 2012read more >
Axxam receives EUR 2.3 million grant from the Italian Ministry of Research to support innovative drug discovery programs3 March 2012read more >